Nanoemulsion Toxin Binding for Liver Detoxification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The liver's ability to detoxify and excrete toxins is impaired due to accumulation of heavy metals, mold toxins, and endotoxins, leading to reduced liver function and associated health issues, as conventional oral supplements face challenges in achieving effective bioavailability and simultaneous stimulation of detoxification phases.
Innovation Solution
An intra-oral nanoemulsion blend comprising monolayer surfactant bound particles and bilayer liposomes, along with a solid powder toxin binding composition, is used to enhance liver performance by delivering bioavailable compounds like milk thistle, R-lipoic acid, and other herbs, ensuring simultaneous delivery and bioavailability of multiple detoxification-enhancing agents, and irreversible binding of toxins in the bowel.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional oral supplements are used to deliver detoxification compounds, then the supplement can be administered easily, but the bioavailability is insufficient and multiple phases of detoxification cannot be stimulated simultaneously
Solution Approach 1:
The patent employs a composite delivery system combining liposomes (for water-soluble compounds) and cyclodextrins (for fat-soluble compounds) in a single oral supplement formulation. This composite approach enables simultaneous delivery of multiple detoxification agents with different solubility characteristics, achieving reliable bioavailability without requiring multiple separate supplements.
Solution Approach 2:
The delivery system is designed to perform multiple functions simultaneously: it delivers water-soluble compounds via liposomes, fat-soluble compounds via cyclodextrins, and stimulates multiple phases of detoxification (Phase I, II, and III) concurrently. This multi-functional design resolves the contradiction by making a single supplement system capable of what previously required multiple separate interventions.
2Quantity of substance
If water is consumed to flush the system, then hydration is improved, but toxin elimination is ineffective because toxins are not water soluble
Solution Approach 1:
The patent introduces binding agents (such as activated charcoal, bentonite clay, and chitosan) as intermediaries that bind to water-insoluble toxins in the gastrointestinal tract. These binding agents convert the elimination problem by creating water-soluble toxin-binding complexes that can be excreted in urine and feces, thereby making toxin elimination effective despite the toxins' inherent water insolubility.
3Productivity
If liver detoxification is enhanced, then toxin removal is improved, but toxins may be reabsorbed in the bowel before elimination
Solution Approach 1:
The patent applies preliminary anti-action by administering binding agents that preemptively bind to toxins in the bowel before they can be reabsorbed into the bloodstream. This prevents the harmful reabsorption process from occurring, ensuring that enhanced detoxification leads to complete toxin elimination rather than creating a cycle of excretion and reabsorption.
4Adaptability or versatility
If multiple detoxification compounds are delivered simultaneously, then all phases of detoxification can be stimulated, but achieving effective concentration of all compounds in the bloodstream is difficult
Solution Approach 1:
The patent segments the delivery mechanism into specialized carriers: liposomes for water-soluble compounds and cyclodextrins for fat-soluble compounds. This segmentation allows each type of compound to be delivered via its optimal carrier system, ensuring that all compounds achieve effective concentrations in the bloodstream simultaneously without competing for the same delivery pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoemulsion blend achieves high bioavailability and prolonged concentration of detoxification-enhancing compounds in the bloodstream, while the toxin binding composition prevents reabsorption of excreted toxins, effectively enhancing liver function and toxin elimination.
Implementation Method 1
An intra-oral nanoemulsion blend comprising monolayer surfactant bound particles and bilayer liposomes
Implementation Method 2
monolayer surfactant bound particles
Implementation Method 3
solid powder toxin binding composition... irreversible binding of toxins in the bowel
Data Source
AI summary
An intra-oral, nanoemulsion blend is provided that enhances liver and toxin excretion performance in mammals when orally administered. A solid powder toxin binding composition also is provided that may be used to irreversibly bind the toxins reaching the bowel so that once the toxins are excreted into the bowel, they may not be reabsorbed, and are thus eliminated. A method of administering the nanoemulsion blend and the toxin binding composition to enhance toxin excretion also is described. The nanoemulsion blend is ingestible and edible.